CTLA4 and neoplasm: In line with our results, Santoni et al [52] reported similar findings in thymoma cases stating that tumour-associated CTLA-4 could promote tumour progression and poor outcome by inhibiting the anti-tumour T cell immunity and inducing tumour-specific T cell apoptosis.